Catyalyst Pharmaceutical Partners (CPRX) Cuts Q2 Loss by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) reported Q2 EPS of ($0.06), versus ($0.07) reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Express (AXP) Tops Q3 EPS by 84c, Misses on Revenue, Raises FY Guidance
- GrafTech International Ltd. (EAF) Misses Q3 EPS by 39c
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
